Physician profile
William Wallace
NPI 1992183412
$706.38
in general payments reported to CMS, 2019-2025
11 companies · $192 in 2025
The $192 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $170 · 2022: $94.46 · 2023: $162 · 2024: $88.63 · 2025: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $442.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $442.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $240.56 | 2021-2025 | Pico, Grafix Pl, Stravix |
| Pacira Pharmaceuticals Incorporated | $107.20 | 2021-2025 | Zilretta, Iovera |
| Boston Scientific Corporation | $78.01 | 2021-2025 | Varithena Administration Pack |
| Endo Pharmaceuticals INC. | $61.59 | 2021-2023 | Xiaflex |
| Endo USA, INC. | $48.02 | 2024-2025 | Xiaflex |
| Orthofix Medical, INC. | $36.02 | 2021-2023 | Physio-Stim |
| Heron Therapeutics, INC. | $35.82 | 2021-2022 | |
| Depuy Synthes Sales INC. | $33.82 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $27.49 | 2023 | Seglentis |
| Ossur Americas, INC. | $19.59 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $18.26 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Wallace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.